Integrum Reinforces Commitment to Osseointegration Innovation
Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) has proudly announced its role as the exclusive Legacy Sponsor for the esteemed Global Collaborative Congress on Osseointegration (GCCO). This prestigious event, which gathers professionals from all over the world, focuses on advances in the field of osseointegration, particularly in bone-anchored prosthetics.
This exclusive sponsorship is set to last for the next three years, granting Integrum the highest tier of recognition within the event. Such a commitment showcases the company’s ongoing dedication to fostering clinical education, surgical innovation, and international collaboration aimed at enhancing the delivery of care for individuals experiencing limb loss.
"We are thrilled to represent the top sponsorship tier at the GCCO conference. This alliance highlights our mutual goal of promoting innovation and collaboration on a global scale to improve limb loss care. Our focus remains on the power of collective knowledge and scientific evidence to create meaningful, lasting impacts," remarked Jeffrey Zanni, President of Integrum Inc.
The conference acts as a meeting point for leaders excelling in the domains of surgical innovation, rehabilitation, prosthetics, and clinical research. Together, they strive to propel the advancements happening in the osseointegration arena.
Dr. Joseph Hsu, conference chair and orthopedic trauma surgeon, emphasized Integrum’s contributions: "Integrum's backing is vital in propelling GCCO's mission — which is to connect experts worldwide to push the envelope of limb loss care. Their unwavering focus on innovation and education not only enriches our discussions but also facilitates enhanced outcomes for amputees globally."
As a Legacy Sponsor, Integrum aims to provide enhanced mobility solutions for individuals by focusing on improving outcomes and facilitating access to cutting-edge prosthetic solutions. The company is steadfast in its mission to support GCCO and to strengthen shared goals within the osseointegration landscape.
For detailed insights into Integrum's offerings or the OPRA™ Implant System, visit the official website. Registration and further information regarding the upcoming GCCO conference can be easily accessed through the registration portal.
For further inquiries, please reach out to:
Jeffrey Zanni, President US
Phone: +1 617-839-1600
Jörgen Svanström, CFO
Mobile: +46 (0) 7073 496 60
Certified Adviser
The Certified Adviser for the Company is DNB Carnegie Investment Bank AB.
Frequently Asked Questions
What is the significance of Integrum's sponsorship at GCCO?
Integrum’s sponsorship highlights its commitment to advancing clinical education and collaboration in the field of osseointegration.
Who is the President of Integrum Inc.?
Jeffrey Zanni serves as the President of Integrum Inc., leading the charge in the company's initiatives.
How long is Integrum's sponsorship for the GCCO conference?
The sponsorship is set for a duration of three years, emphasizing long-term investment in limb loss care.
What does the GCCO conference focus on?
The GCCO conference centers on surgical innovation, rehabilitation, and enhancing care for individuals with limb loss.
What is the mission of Integrum related to osseointegration?
Integrum aims to provide freedom of mobility and improve outcomes through advanced prosthetic solutions in osseointegration.
